This edition includes: • REZDIFFRA™ (Resmetirom): A New Hope for Patients with Advanced Fibrosis in...
Read More
Survodutide has an “acceptable safety profile” in patients with metabolic dysfunction-associated steatohepatitis with compensated and decompensated cirrhosis,...
Texas Liver Institute’s Dr. Eric Lawitz and colleagues publish clinical trial results on 2...
This edition contains: • Introducing Andrés Gómez-Aldana, Transplant Hepatologist • Sugar, Sweeteners, and Liver • Cancer:...
Learn a little about the history of liver transplantation and exciting emerging areas in...
Reference: https://www.universityhealth.com/news/university-health-transplant-institute-named-best-liver-transplant-program-in-country
Listen to Dr. Rodas discuss the management of non-alcoholic fatty liver disease in patients...